Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2401 AL 2415

Amyloid-beta: a crucial factor in Alzheimer's disease

Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J.

Med Princ Pract. 2015;24(1):1-10. doi: 10.1159/000369101. Epub 2014 Nov 27.

Focus on GABA(A) receptor function. A comparative analysis of in vivo imaging studies in neuropsychiatric disorders

Nikolaus S, Hautzel H, Müller HW.

Nuklearmedizin. 2014;53(6):227-37. doi: 10.3413/Nukmed-0647-14-03. Epub 2014 Aug 27.

Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort

Teng E, Chow N, Hwang KS, Thompson PM, Gylys KH, Cole GM, Jack CR Jr, Shaw LM, Trojanowski JQ, Soares HD, Weiner MW, Apostolova LG; Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2015;39(3-4):154-66. doi: 10.1159/000368982. Epub 2014 Dec 24.

Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective

Lewczuk P, Mroczko B, Fagan A, Kornhuber J.

Adv Med Sci. 2015 Mar;60(1):76-82. doi: 10.1016/j.advms.2014.11.002. Epub 2014 Dec 9.

[Diagnosis and treatment of dementia: overview]

Furukawa K, Ishiki A, Tomita N, Arai H.

Rinsho Shinkeigaku. 2014;54(12):1171-3. doi: 10.5692/clinicalneurol.54.1171.

Alzheimer's disease and the quest for its biological measures

Praticò D.

J Alzheimers Dis. 2013;33 Suppl 1:S237-41. doi: 10.3233/JAD-2012-129023.

Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?

Zetterberg H, Blennow K.

J Alzheimers Dis. 2013;33 Suppl 1:S361-9. doi: 10.3233/JAD-2012-129035.

Trait, state, and mechanism: looking back, looking forward, and understanding why

Lovestone S.

J Alzheimers Dis. 2013;33 Suppl 1:S23-33. doi: 10.3233/JAD-2012-129014.

Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease

Teipel SJ, Sabri O, Grothe M, Barthel H, Prvulovic D, Buerger K, Bokde AL, Ewers M, Hoffmann W, Hampel H.

J Alzheimers Dis. 2013;33 Suppl 1:S329-47. doi: 10.3233/JAD-2012-129030.

Biomarkers for Alzheimer's disease: showing the way or leading us astray?

Quinn JF.

J Alzheimers Dis. 2013;33 Suppl 1(Suppl 1):S371-6. doi: 10.3233/JAD-2012-129022.

Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease

Pacheco-Quinto J, Herdt A, Eckman CB, Eckman EA.

J Alzheimers Dis. 2013;33 Suppl 1(0 1):S101-10. doi: 10.3233/JAD-2012-129043.

Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia

Le Bastard N, Coart E, Vanderstichele H, Vanmechelen E, Martin JJ, Engelborghs S.

J Alzheimers Dis. 2013;33(1):117-31. doi: 10.3233/JAD-2012-121246.

Modulation of murine Alzheimer pathogenesis and behavior by surgery

Tang JX, Mardini F, Janik LS, Garrity ST, Li RQ, Bachlani G, Eckenhoff RG, Eckenhoff MF.

Ann Surg. 2013 Mar;257(3):439-48. doi: 10.1097/SLA.0b013e318269d623.

At the end of a very hard day, people find some reason to believe

Robert P.

J Alzheimers Dis. 2013;34(1):295-6. doi: 10.3233/JAD-121637.

Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study

Gabelle A, Dumurgier J, Vercruysse O, Paquet C, Bombois S, Laplanche JL, Peoc'h K, Schraen S, Buée L, Pasquier F, Hugon J, Touchon J, Lehmann S.

J Alzheimers Dis. 2013;34(1):297-305. doi: 10.3233/JAD-121549.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias